Get involved: send your pictures, video, news and views by texting GAZETTE NEWS to 80360, or email
10:00am Monday 13th October 2008 in
A £1 million investment will mean patients in north Essex get access to sight-saving drugs.
NHS North East Essex (formerly North East Essex Primary Care Trust) has introduced funding for a drug called Lucentis, which is used to treat people with wet age-related macular degeneration.
It is a condition which affects the part of the eye used for seeing fine detail and as it progresses, the person can lose their sight.
Injections of Lucentis into the eye are used to treat the condition.
Mary Tompkins, assistant director of medicines management for NHS North East Essex, said: “Wet age-related macular degeneration is a key focus for NE Essex PCT, and funding for Lucentis is now available for patients diagnosed with this problem."
Enter your postcode, town or place name
Search for hundreds of jobs in Essex and beyond
Search Now »
Bring love into your life! Find a date in Essex
Search Now »
Homes for sale, and to let, in Essex
Search Now »
New and used cars in Essex and across the UK
Search Now »
Comment now! Register or sign in below.
Log in with us
Fields marked with * are mandatory.
Or
Log in with